Navigation Links
Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis
Date:5/24/2011

Portfolio Planning

Part II: Lymphoma

The lymphoma report part comprises defined and up to date development strategies for 282 lymphoma drugs within the portfolio of 154 investigators, from Ceased to Marketed. This part extensively analyses their 181 identified drug targets, organized into 173 drug target strategies, and assesses them in eight different compound strategies and five subindications of lymphoma.

This part is based on the following publication:

A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market

Part III: Angiogenesis

The angiogenesis report part comprises defined and up to date development strategies for 239 drugs affecting angiogenesis in oncology within the portfolio of 148 investigators, from Preclinical to Marketed. This report part extensively analyses 174 identified targets of angiogenesis affecting drugs, organized into 167 drug target strategies, and assesses them in 64 different cancer indications.

This part is based on the following publication:

Commercializing Cancer Drugs Affecting Angiogenesis: A Decision Support Tool for Optimizing the Pipeline

The report is written for you to understand and assess the impact of competitor entry and corresponding changes to development strategies for your own portfolio products. It helps teams to maximize molecule value by selecting optimal development plans and manage risk and uncertainty. The report serves as an external commercial advocate for pharmaceutical companies' pipeline and portfolio planning (PPP) in cancer by:

* Providing you with competitive input to the R&D organization to guide development of early product ideas and ensure efforts are aligned with business objectives

* Assisting you to make informed decisions in selecting cancer indications that are known to be appropriate for your drug's properties

* Analyzing, correlating and integrating valuable data s
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Reportlinker Adds Triple Analysis: Lymphoma, Melanoma and Peptides
2. Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Peptides
3. Reportlinker Adds Advanced Digital Medical Equipment Products Market
4. Reportlinker Adds India Medical Devices Manufacturers, Distributors and Exporters Directory 2011
5. Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market
6. Reportlinker Adds Orphan Drugs in Asia 2011
7. Reportlinker Adds Global Water Market Outlook: Strategic Analysis of Water and Wastewater Management in the Pharmaceutical Industry
8. Reportlinker Adds The Outlook for Medical Devices in South East Asia
9. Reportlinker Adds Pharmaceutical Management of Obesity (Technical Insights)
10. Reportlinker Adds Machine-to-Machine (M2M) Communications in Healthcare 2010-20
11. Reportlinker Adds Hong Kong SMBG Devices and Strips Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 The board ... LLY ) has declared a dividend for the ... outstanding common stock. The dividend is ... the close of business on August 15, 2013. ... growing portfolio of pharmaceutical products by applying the latest ...
(Date:6/18/2013)... , June 18, 2013 New-generation ... being highly portable and lightweight. Simultaneously, circuitry is ... the processing speed to which it performs at. ... medical electronics and military equipment, such as cameras ... Omnetics, micro-circular and nano-circular connectors include custom cable ...
(Date:6/18/2013)... , June 18, 2013  Healthgrades, the leading ... and connect with physicians and hospitals, today issued ... in" When Making Healthcare Decisions to Get Your ... performing hospitals for maternity care, gynecologic surgery, as ... of women across 15 of the most common ...
Breaking Medicine Technology:Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 4
... Dosing of Delayed-ReleaseCysteamine in Collaboration,with UC, San ... Raptor,Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC ... patient dosing in a Phase 2a,clinical trial, ... San,Diego ("UCSD"), to evaluate cysteamine bitartrate ("cysteamine") ...
... MOORESVILLE, N.C., Oct. 17 Anpath Group, ... its wholly-owned,subsidiary, EnviroSystems, Inc. (ESI) announced that ... purchased additional,supplies of its EnviroTru(R) Disinfectant & ... efficiency electrostatic mobile spraying units., The ...
Cached Medicine Technology:Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH) 2Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH) 3Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH) 4Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH) 5Anpath Group, Inc. Advances Relationship With the Washington Metropolitan Area Transit Authority (Metro) 2Anpath Group, Inc. Advances Relationship With the Washington Metropolitan Area Transit Authority (Metro) 3Anpath Group, Inc. Advances Relationship With the Washington Metropolitan Area Transit Authority (Metro) 4
(Date:6/18/2013)... June 18, 2013 Two months ago, Suyima ... into surgery for a second session of a silicone treatment ... County. The treatment was allegedly performed by a mystery Venezuelan ... board. According to Dr. Bernabe Vazquez of Bayshore ... such treatments from doctor’s who are not board certified is ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Today, Zane ... Health Reimbursement Accounts . Zane Benefits, which provides comprehensive ... is the leader in defined contribution and ... Zane Benefits’ website, employees of a company who sets ... have questions about how Health Reimbursement Accounts work. Educating ...
(Date:6/18/2013)... New York magazine named 145 physicians from ... Doctors” list, up from 129 last year and more than ... also lists 52 additional doctors who serve at hospitals within ... trajectory. The “Best Doctors” issue, which this year features a ... issue and is available online at http://www.nymag.com/bestdoctors . , ...
(Date:6/18/2013)... cells in the mammary gland appear to provide a ... in life, and the subsequent development of breast cancer, ... July 2013 issue of the journal Cancer Prevention ... be associated with an increased risk of certain types ... biology of social stress to cancer have been hard ...
(Date:6/18/2013)... Obama officially declared June as Lesbian, Gay, ... despite advances in civil rights, sexual minority ... suicide than their heterosexual peers, according to ... of Missouri psychology graduate student recently published ... minority youth, which could help improve psychological ...
Breaking Medicine News(10 mins):Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 3Health News:Zane Benefits Publishes New Information on Health Reimbursement Accounts 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4Health News:Sexual minority youth need specialized treatment from therapists 2
... the reason why isolated women are less vulnerable to falling ill ... ,The study is an eye-opener to the upcoming proof that ... a clue to the reason why socially isolated men are prone ... have shown a connection between stress and immune function. But this ...
... Bachoud-Lévi, M.D., and colleagues of the French national institute ... Huntington's disease// who previously received intracerebral fetal neural grafts ... ,But the same investigators reported today that ... years and then began to decline over the next ...
... at University of California have gained valuable insights about ... , a finding that may eventually accelerate current research ... is a joint effort by Dr. Frank Sauer (UCR ... Munich) and other researchers from University of California. The ...
... School of Public Health are one of the 14 ... Environmental Health Sciences// (NIEHS) to study the association between ... is a new study to control the rising obesity ... an individual’s body size. Working with various city departments, ...
... Research Institutes, Inc (NDRI) in New York City ... the role// of social supports, spirituality, religiousness, life ... recovery from addiction. The study reveals markedly improved ... a decrease in stress when people were inclined ...
... fear regarding the elevated risk of lymphoma associated with ... has found that such treatments may not confer an ... be seen in the latest issue of Arthritis & ... been found to increase with worsening of the chronic ...
Cached Medicine News:Health News:Women Portray Stronger Immune Response As Compared to Men, Study Suggests 2Health News:Fetal Neural Grafts Improves Motor and Cognitive Function in Huntington Patients 2Health News:Drug Addiction Recovery Buffered by Spirituality 2Health News:No Lymphoma Risk From Rheumatoid Arthritis Drugs 2
Facilitates intubation of tracheal tubes....
SunGlide™ Stylette - Blue Neonatal. Use in 2.0 to 3.5mm tubes. 25/box....
Hollow Copper Tube with Suction Port 16.5....
Surgical Stainless Steel Adult 16.5....
Medicine Products: